NCT02540486 Long Acting Insulin Glargine Titration Web Tool (LTHome) vs Enhanced Usual Therapy of Glargine Titration Status COMPLETED Phase NA
NCT02536937 A Study of the Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate Status COMPLETED Phase PHASE1
NCT02531152 28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE1
NCT02531035 A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone Status COMPLETED Phase PHASE3
NCT02528214 Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma Status COMPLETED Phase PHASE3
NCT02520102 Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous Leukemia Status WITHDRAWN Phase PHASE2
NCT02517385 Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases Status COMPLETED Phase PHASE3
NCT02514668 A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT02513186 Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate Transplantation Status COMPLETED Phase PHASE1
NCT02512458 Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer Status COMPLETED Phase PHASE2
NCT02497612 To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria Status TERMINATED Phase PHASE2
NCT02485691 Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent Status COMPLETED Phase PHASE4
NCT02481258 A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification Status COMPLETED Phase PHASE2
NCT02478502 Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer Status TERMINATED Phase PHASE2
NCT02476006 Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE) Status COMPLETED Phase PHASE3
NCT02469116 Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma Status TERMINATED Phase PHASE2
NCT02459899 Dose-ranging Study in Patients With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT02451137 A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM) Status COMPLETED Phase PHASE4